CPV – Page 36 – Pharma.Tips

Exhaust inefficiency during film coating – process robustness improvement

Improving Process Robustness to Address Exhaust Inefficiency in Film Coating The pharmaceutical industry is continually striving for process optimization and manufacturing excellence to meet GMP (Good Manufacturing Practice) standards while…

Tablet twinning tendency during continuous coating – process robustness improvement

Improving Process Robustness Against Tablet Twinning during Continuous Coating Tablet twinning tendency during continuous coating is a prevalent issue in pharmaceutical manufacturing that can compromise product quality and yield. Manufacturers…

Over-coating risk post-validation – process robustness improvement

“`html Enhancing Process Robustness to Mitigate Over-Coating Risks After Validation In the world of pharmaceutical manufacturing, over-coating presents a significant challenge that can undermine product quality, reduce yield, and lead…

FBD air distribution issue during scale-up – GMP-compliant drying improvement

Improving GMP Compliance in FBD Operations During Scale-Up In the realm of pharmaceutical manufacturing, the scale-up of processes can often unveil significant challenges, particularly regarding air distribution in Fluid Bed…

Extended drying time during CPV review – GMP-compliant drying improvement

Addressing Extended Drying Time During CPV Review for Optimized GMP Compliance The drying process in pharmaceutical manufacturing is critical, not only for product quality but also for regulatory compliance. When…

Extended drying time during granulation drying – process efficiency optimization strategy

Strategies to Mitigate Extended Drying Time in Granulation Processes Manufacturing pharmaceutical products is a complex endeavor that demands strict adherence to quality standards and operational efficiency. One of the persistent…

Extended drying time during CPV review – process efficiency optimization strategy

Optimizing Process Efficiency in Response to Extended Drying Times During CPV Review In pharmaceutical manufacturing, extended drying times during Continuous Process Verification (CPV) not only impact productivity but can also…

FBD air distribution issue during scale-up – inspection justification readiness

Addressing FBD Air Distribution Issues During Scale-Up to Ensure Inspection Readiness The scaling up of Fluidized Bed Dryers (FBD) is a critical process in pharmaceutical manufacturing, often fraught with challenges…

FBD air distribution issue during granulation drying – process efficiency optimization strategy

Addressing Air Distribution Challenges in FBD During Granulation Drying for Enhanced Process Efficiency In the highly regulated pharmaceutical manufacturing environment, ensuring optimal conditions for granulation drying is critical. A common…

Over-drying risk during CPV review – GMP-compliant drying improvement

Mitigating Over-Drying Risks in CPV Reviews for GMP-Compliant Drying Processes In pharmaceutical manufacturing, managing the drying process is critical to ensure product quality and compliance. Over-drying not only affects the…

FBD air distribution issue during validation – process efficiency optimization strategy

Optimizing FBD Air Distribution Issues During Validation for Enhanced Process Efficiency Fluid Bed Dryers (FBD) are critical in various pharmaceutical manufacturing processes, ensuring optimal drying and processing of active ingredients…

Non-uniform drying during scale-up – GMP-compliant drying improvement

Improving Non-uniform Drying During Scale-up in Compliance with GMP Guidelines In pharmaceutical manufacturing, maintaining consistent product quality is paramount. Non-uniform drying during scale-up poses significant challenges, including variations in moisture…